Gotham Makker - 14 Jun 2021 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Sara Turken, as attorney-in-fact
Issuer symbol
RCKT
Transactions as of
14 Jun 2021
Transactions value $
$44,983
Form type
4
Filing time
16 Jun 2021, 20:13:40 UTC
Next filing
21 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +12.2K $0.00 12.2K 14 Jun 2021 Common Stock 12.2K $47.25 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $45K +1.53K $29.42 1.53K 14 Jun 2021 Common Stock 1.53K $47.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022.
F2 This option represents a right to purchase a total of 1,529 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option was issued to the Reporting Person in lieu of director retainer fees of $45,000.